SKSara Kazempour-Ardebili

Sara Kazempour-Ardebili

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Interests


Sara Kazempour-Ardebili has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Andrew H. Frankel

    Imperial College Kidney and Transplant Institute, Division of Medicine, Hammersmith Hospital, London, U.K.

    2 shared publications
  • Anne Dornhorst

    Department of Medicine, Imperial College London, Hammersmith Campus, London, U.K.

    2 shared publications
  • Frederick W.K. Tam

    Imperial College Kidney and Transplant Institute, Division of Medicine, Hammersmith Hospital, London, U.K.

    2 shared publications
  • Gary Frost

    Department of Investigative Medicine, Imperial College London, Hammersmith Campus, London, U.K.

    2 shared publications
  • Jeremy J.O. Turner

    Department of Investigative Medicine, Imperial College London, Hammersmith Campus, London, U.K.

    2 shared publications
  • Thushara Dassanyake

    Imperial College Kidney and Transplant Institute, Division of Medicine, Hammersmith Hospital, London, U.K.

    2 shared publications

Latest Publications

  • Open Access

    Assessing Glycemic Control in Maintenance Hemodialysis Patients With Type 2 Diabetes

    by Sara Kazempour-Ardebili, Varunika L. Lecamwasam, Thushara Dassanyake, Andrew H. Frankel, Frederick W.K. Tam, Anne Dornhorst, Gary Frost, Jeremy J.O. Turner

  • Open Access

    Assessing Glycemic Control in Maintenance Hemodialysis Patients With Type 2 Diabetes

    by Sara Kazempour-Ardebili, Varunika L. Lecamwasam, Thushara Dassanyake, Andrew H. Frankel, Frederick W.K. Tam, Anne Dornhorst, Gary Frost, Jeremy J.O. Turner

    OBJECTIVE: Optimizing glycemic control in diabetic patients undergoing maintenance hemodialysis requires accurate assessment. We hypothesize that 1) 48-h continuous glucose monitoring (CGM) provides additional, clinically relevant, information to that provided by the A1C measurement and 2) glycemic profiles differ significantly between day on and day off dialysis. RESEARCH DESIGN AND METHODS: With the use of GlucoDay S, 48-h CGM was performed in 19 type 2 diabetic subjects undergoing hemodialysis to capture consecutive 24-h periods on and off dialysis. Energy intake was calculated using food diaries. A1C was assayed by a high-performance liquid chromatography method. RESULTS: CGM data were available for 17 subjects (13 male) with a mean (range) age of 61.5 years (42–79 years) and diabetes duration of 18.8 years (4–30 years). The 24-h CGM area under the glucose curve and 24-h mean glucose values were significantly higher during the day off dialysis than on dialysis (5,932.1 ± 2,673.6 vs. 4,694 ± 1,988.0 mmol · 3 min−1 · l−1, P = 0.022, and 12.6 ± 5.6 vs. 9.8 ± 3.8 mmol/l, P = 0.013, respectively), independent of energy intake. Asymptomatic hypoglycemia occurred in 4 subjects, 3 within 24 h of dialysis, and the glucose nadir in 14 subjects occurred within 24 h of dialysis. CONCLUSIONS: Glucose values are significantly lower on dialysis days than on nondialysis days despite similar energy intake. The risk of asymptomatic hypoglycemia was highest within 24 h of dialysis. Physicians caring for patients undergoing hemodialysis need to be aware of this phenomenon and consider enhanced glycemic monitoring after a hemodialysis session. CGM provides glycemic information in addition to A1C, which is potentially relevant to clinical management.